The CRISPR-Cas9 system, naturally a defense mechanism in prokaryotes, has been repurposed as an RNA-guided DNA targeting platform. It has been widely used for genome editing and transcriptome modulation, and has shown great promise in correcting mutations in human genetic diseases. Off-target effects are a critical issue for all of these applications. Here we review the current status on the target specificity of the CRISPR-Cas9 system.

Alternative splicing is a ubiquitous mechanism of post-transcriptional regulation of gene expression and produces multiple isoforms from the same genes. Expression quantitative trait loci (eQTL) has been a major method for finding associations between gene expression and genomic variations. Differences in alternative splicing isoforms are resulted from differences in the expression of exons. We propose to use exon expression QTL (eeQTL) to study the genomic variations that are associated with splicing regulation. A stringent criterion was adopted to study gene-level eQTLs and exon-level eeQTLs for both cis- and trans- factors. From experiments on an RNA-sequencing (RNA-Seq) data set of HapMap samples, we observed that compared with eQTLs, more eeQTL trans-factors can be found than cis-factors, and many of the eeQTLs cannot be found at the gene level. This work highlights that the regulation of exons adds another layer of regulation on gene expression, and that eeQTL analysis is a new approach for investigating genome-wide genomic variations that are involved in the regulation of alternative splicing.